| Literature DB >> 27576518 |
Dongling Dai1,2, Feiqiu Wen3, Sixi Liu2, Shaoming Zhou2.
Abstract
BACKGROUND: Both haemophagocytic lymphohistiocytosis and acute necrotizing encephalopathy are life-threatening condition. It presents major diagnostic difficulties, since it may have a diversity in clinical picture and with many conditions leading to the same clinical presentation. So it is key important to understand the disorders. CASEEntities:
Keywords: Acute necrotizing encephalopathy of childhood; Brain damage; Haemophagocytic lymphohistiocytosis; Hypersensitivity
Mesh:
Year: 2016 PMID: 27576518 PMCID: PMC5006504 DOI: 10.1186/s13052-016-0286-z
Source DB: PubMed Journal: Ital J Pediatr ISSN: 1720-8424 Impact factor: 2.638
The main laboratory parameters detected in this patient
| Laboratory parameters | Reference value | Results | |
|---|---|---|---|
| Rheumatoid factor | 0–20 IU/ml | <20 | |
| Anti-streptolysin “O” | 0–200 IU/ml | <25 | |
| C-reactive protein | 0–10 mg/L | 19.5 | |
| Anti-cyclic-citrullinated peptide antibody | – | Negative | |
| Autoantibodies | Antinuclear antibody | – | Positive |
| Antineutrophil cytoplasmic antiboby | – | Positive | |
| Anti jo-1 antibody | – | Negative | |
| Anti-centromere antibody | – | Negative | |
| Anti-double-stranded dna antibody | – | Negative | |
| Anti-histone antibody | – | Negative | |
| Antismith antibody | – | Negative | |
| Anti-rnp antibody | – | Negative | |
| Anti-SS A antibody | – | Negative | |
| Anti-SS B antibody | – | Negative | |
| Anti-ribosomal antibody | – | Negative | |
| Anti-Sc1-70 antibody | Negative | ||
| Anti-nucleosome antibody | – | Negative | |
| Lymphocyte subsets | CD3+ T cell | 68 % ± 10.7 % | 66.1 % |
| CD4+ T cell | 31.5 % ± 8.8 % | 34.2 % | |
| CD8+ T cell | 25.7 % ± 6.5 % | 19.66 % | |
| CD19 B cell | 15.6 % ± 5.8 % | 19.1 % | |
| NK cell | 5.6 % - 31 % | 9 % | |
| CD4+/CD8+ | 1.5 ± 0.5 | 1.74 | |
| Ig isotypes | IgG | 3.22 – 14.0 g/L | 6.39 |
| IgM | 0.57 – 1.41 g/L | 0.82 | |
| IgA | 0.24 – 1.79 g/L | 0.43 | |
| Complement C3 | 0.8 – 1.6 g/L | 0.74 | |
| Complement C4 | 0.1 – 0.4 g/L | 0.18 | |
| Total IgE | 0 – 20 KIU/L | 104.4 | |
| Ammonia | 9 – 30 umol/L | 19 | |
| Lactic acid | 0.7 – 2.1 mmol/L | 1.22 | |
| Coagulation test | Activated partial thromboplastin time | 26.1 – 40.73 s | 29.7a, over the upper limit of detectionb |
| Prothrombin time | 9.3 –12.9 s | 12.8a, over the upper limit of detectionb | |
| International normalized ratio | 0.72 – 1.15 | 1.09a, over the upper limit of detectionb | |
| Thrombin time | 13.2 – 20.1 s | 20a, over the upper limit of detectionb | |
| Fibrinogen | 1.57 – 3.93 g/L | 2.43a, 0.49b | |
| Blood lipid levels | Total cholesterol | 3.1 – 5.8 mmol/L | 1.78a, 3.62b |
| Triglyceride | 0.23 – 1.7 mmol/L | 2.54a, 4.53b | |
| High density lipoprotein | 0.9 – 1.8 g/L | 0.47a, 1.05b | |
| Low density lipoprotein | 2.07 – 4.1 g/L | 1.1a, 1.8b | |
| Serum ferritin | 22 – 322 ng/ml | 15.4a, 18699b | |
| Values of eosinophils | 0.02 – 0.5 × 109/L | 0.26a, 4.01c, 0.01d | |
Note: a - on admission, b - peak period of disease, c - the 2nd day after first IVIG, d - when severe pancytopenia
Fig. 1Hemophagocytic histiocytes in bone marrow. Bone marrow aspiration showing a normal histiocyte (a), a hemophagocytic histiocyte containing aphagocytosed neutrophil and platelets (b), a hemophagocytic histiocyte containing aphagocytosed erythroblast and platelets (c). (Wright staining; ×1000)
Fig. 2Neurological images. Brain magnetic resonance imaging (MRI) on admission revealed extensive edema (a); after 4 weeks, it showed long T2 signal (b) and hyperintensity on fluid-attenuated inversion recovery (FLAIR, c) mainly in thalamus, basal ganglia, brainstem. 1 year later, the neurological image (MRI) showed slightly abnormal shape of bi-lateral ventricular, not any other obvious abnormal changes noticed (d)
Variations of the HLH related genes and the references [34]
| Gene | Exons | Function | Variation | rs number | MAF | Clinical significance |
|---|---|---|---|---|---|---|
| PRF1 | EXON3 | Synonymous | c.900C > T p.His300His | rs885822 | 0.3041 | |
| UNC13D | EEXON1 | Intron | c.117 + 59C > T | rs3744010 | 0.2847 | |
| EXON4 | Synonymous | c.279C > T p.Pro93Pro | rs3744007 | 0.1000 | ||
| EXON5 | Intron | c.388 + 122C > T | rs3744006 | 0.4930 | ||
| EXON11 | Synonymous | c.888G > C p.Pro296Pro | rs7223416 | 0.4902 | ||
| EXON18 | Intron | c.1596 + 36A > G | rs3744026 | 0.3083 | ||
| EEXON19 | Intron | c.1728-48 T > C | rs3744024 | 0.3025 | ||
| EXON21 | Synonymous | c.1977C > T p.Thr659Thr | rs2290770 | 0.0799 | ||
| EXON24 | Intron | c.2299-46C > T | rs7212635 | 0.2542 | ||
| EXON28 | Intron | c.2709 + 48C > T | rs2290768 | 0.2530 | ||
| EEXON32 | Synonymous | c.3198A > G.Glu1066Glu | rs7210574 | 0.4738 | ||
| STX11 | No mutation | |||||
| STXBP2 | Exon2 | Intron | c.38-7C > T | rs113939878 | NA | acceptor |
| Exon10 | Synonymous | c.816 C > T p.Ser272Ser | rs78010345 | 0.0034 | ||
| EXON15 | Intron | c.1247-43 T > C | rs929807 | 0.4730 | ||
| EXON15 | Intron | c.1356 + 18A > G | rs889187 | 0.4836 | ||
| Exon16 | Synonymous | c.1443 T > C .Asp481Asp | rs10001 | 0.4958 | ||
| Exon18 | Intron | c.1696 + 28G > C | rs34976997 | 0.3157 | ||
| Exon18 | Intron | c.1696 + 77G > A | rs794074 | 0.4615 | ||
| Exon19 | Intron | c.1697-26 T > G | rs794073 | 0.465 | ||
| XIAP | Exon5 | Intron | c.1099 + 264G > C | rs28382732 | 0.2638 | |
| Exon7a | 3' UTR | c.*12A > G | rs28382740 | 0.2673 | ||
| SH2D1A | No mutation | |||||
Note: MAF - minor allele frequency; UTR, untranslated region